Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|April 9, 2019
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantationNicolas Stocker, Remy Duléry, Giorgia Battipaglia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2022
Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantationNicolas Stocker, Virginie Baltes, Solal Bellaiche, et al.
Bone Marrow Transplantation|September 29, 2019
Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomesNicolas Stocker, Myriam Labopin, Inès Boussen, et al.
Clinical Hematology International|January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective studyNicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 10, 2024
Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with Acalabrutinib-findings from three casesMarion Blaize, Guillaume Thizy, Alexandre Boissonnas, et al.
Clinical & Translational Immunology|October 2, 2020
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graftNicolas Stocker, Béatrice Gaugler, Myriam Labopin, et al.
Journal of Clinical Immunology|June 1, 2024
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell TransplantationLama Siblany, Nicolas Stocker, Laure Ricard, et al.
Bone Marrow Transplantation|October 12, 2022
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantationAnne Banet, Ali Bazarbachi, Myriam Labopin, et al.
Clinical Hematology International|May 31, 2024
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impactAnnalisa Paviglianiti, Tânia Maia, Joël-Meyer Gozlan, et al.
Cancers|August 26, 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)Marion Detroit, Mathis Collier, Nathanaël Beeker, et al.
Pageof 4